ArticleGalen medical journal2024
Comparative Effects of Liquid and Solid Concentrated Growth Factors, and Injectable and Advanced Platelet-rich Fibrin on Proliferation and Differentiation of Human Dental Pulp Stem Cells : Comparative Effects on Proliferation and Differentiation of Human Dental Pulp Stem Cells.
Article in Galen medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study compared the effects of liquid (L-CGF) and solid (S-CGF) concentrated growth factors, and injectable (I-PRF) and advanced (A-PRF) platelet-rich fibrin on the proliferation and differentiation of human dental pulp stem cells (DPSCs). Materials and Methods: Blood samples were collected to prepare A-PRF, I-PRF, L-CGF, and S-CGF according to the standard protocols. DPSCs were exposed to the biomaterials, and their proliferation was quantified after 24 hours and 5 days using the methyl thiazolyl tetrazolium (MTT) assay. Cell differentiation was histologically assessed by Alizarin red staining. Expression of osteocalcin (OCN), osteopontin (OPN), and RUNX2 genes was assessed in non-osteogenic medium, and osteogenic medium after 7 and 14 days by real-time polymerase chain reaction (PCR). Results: The mean cell proliferation was not significantly different among the study groups (P=0.324) and did not significantly change over time (P=0.346). S-CGF, L-CGF, and A-PRF showed a significant difference in OCN expression (P0.001). The mean expression of OCN at 7 days was significantly lower in non-osteogenic medium. The mean expression of OCN and OPN at 7 days was significantly lower than 14 days. The mean expression of OPN at different time points was significantly different in A-PRF (P0.002), L-CGF (P0.003), and I-PRF (P0.003) groups. The mean expression of RUNX2 was significantly different at different times in L-CGF group, and a significant difference existed in the expression of RUNX2 in non-osteogenic medium and at 14 days. Conclusion: Within the limitations of the present study, the results showed that A-PRF, I-PRF, L-CGF, and S-CGF can increase the proliferation and differentiation of human DPSCs by regulating gene expression, and can be suitable options for osteogenesis. There was no significant difference in terms of mean cell proliferation among the study groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.